Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)

NCT03595202 is registered in ClinicalTrials.gov with Taisho Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT03595202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03595202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)
Lead sponsor
Taisho Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
April 3, 2017
Completion date
July 7, 2017
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants